FDA approves new long-lasting sunscreen ingredient
FDA approves new long-lasting sunscreen ingredient
Updated at: August 1, 2026 at 05:00 AM
In a major victory for skin health, the U.S.
Food and Drug Administration (FDA) officially approved bemotrizinol, also known as Tinosorb S, as a new active sunscreen ingredient in June 2026.
This is the first time in nearly 30 years that the FDA has updated its over-the-counter sunscreen monograph.
Bemotrizinol is a powerful, broad-spectrum UV filter capable of blocking both UVA and UVB rays efficiently on its own.
It has been classified as Generally Recognized as Safe and Effective (GRASE) for adults and children as young as six months.
One of the most exciting aspects of bemotrizinol is its photostability, meaning it resists breaking down under sunlight, offering longer-lasting protection.
Additionally, dermatologists praise its cosmetic elegance, as it creates non-greasy, transparent formulas that are pleasant to wear.
By closing a long-standing gap in technology, this approval promises to make daily sun protection easier and more effective for Americans, ultimately helping to combat rising rates of skin cancer through better, more consistent habits.
